Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 32.09 CNY -5.34% Market Closed
Market Cap: 24.7B CNY
Have any thoughts about
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Wall Street analysts forecast Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

Lowest
Price Target
46.26 CNY
44% Upside
Average
Price Target
46.72 CNY
46% Upside
Highest
Price Target
48.09 CNY
50% Upside
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors:
Price Targets
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
27% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
61% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
12% Upside
MRK
Merck KGaA
34% Upside
CPH
Cipher Pharmaceuticals Inc
24% Upside
SANOFI
Sanofi India Ltd
37% Upside
086450
Dongkook Pharmaceutical Co Ltd
49% Upside
TLRY
Tilray Brands Inc
71% Upside

Revenue
Forecast

Revenue Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 2%. The projected CAGR for the next 3 years is 8%.

2%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 10%. The projected CAGR for the next 3 years is 27%.

10%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 10%. The projected CAGR for the next 3 years is 18%.

10%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's stock price target?
Price Target
46.72 CNY

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 2%. The projected CAGR for the next 3 years is 8%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 10%. The projected CAGR for the next 3 years is 27%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 10%. The projected CAGR for the next 3 years is 18%.

Back to Top